3Minaguchi T,Nakagawa S,Takazawa Y,et al.Combined phosphoAkt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia,G1 adenocarcinoma of the endometrium[J].Cancer Lett,2007,248(1):112-122.
4Mao Y,Wan X,Chen Y,et al.Outcomes of conservative therapy for young women with early endometrial adenocarcinoma[J].Fertil Steril,2010,93(1):283-285.
5Kim MK,Yoon BS,Park H,et al.Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women:pilot study[J].Int J Gynecol Cancer,2011,21(4):673-677.
7Park JY,Seong SJ,Kim TJ,et al.Pregnancy outcomes after fertilitysparing management in young women with early endometrial cancer[J].Obstet Gynecol,2013,121(1):136-142.
8Gunderson CC,Fader AN,Carson KA,et al.Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade I adenocarecinoma:a system review[J].Gynecol Oncol,2012,125(2):477-482.
9Chiva L,Lapuente F,Gonzalez-Cortijo L,et al,Gonzalez-Martin A.Sparing fertility in young patients with endometrial cancer[J].Gynecol Oncol,2008,111(Suppl 2):S101-S104.
10Park JY,Kim DY,Kim JH,et al.Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer(KGOG2002)[J].Eur J Cancer,2013,49(4):868-874.
